What is the angiographic classification system for Takayasu arteritis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 15, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Takayasu Arteritis Angiographic Classification

The Hata angiographic classification system, established in 1996, divides Takayasu arteritis into six types (I, IIa, IIb, III, IV, and V) based on the anatomical distribution of arterial involvement, with Type V (combined thoracic and abdominal involvement) being the most prevalent pattern globally. 1

The Six Hata Classification Types

The classification system defines involvement patterns as follows:

  • Type I: Branches from the aortic arch only (brachiocephalic, carotid, subclavian arteries)
  • Type IIa: Ascending aorta, aortic arch, and its branches
  • Type IIb: Type IIa plus thoracic descending aorta
  • Type III: Thoracic descending aorta, abdominal aorta, and/or renal arteries (without arch involvement)
  • Type IV: Abdominal aorta and/or renal arteries only
  • Type V: Combined features of Type IIb and Type IV (entire aorta and its branches)

1

Geographic Distribution Patterns

The original Hata study revealed striking geographic differences that remain clinically relevant 1:

  • Japanese pattern: Predominantly affects ascending aorta, aortic arch, and great vessels (thoracic predominance)
  • Indian pattern: Primarily involves abdominal aorta and renal arteries

Type V represents the most common pattern worldwide, with pooled prevalence of 43.49% across populations, while Type III is the rarest at 5.32% 2. The 2010 ACC/AHA guidelines specifically note these two distinct disease distributions 3.

Clinical Significance and Prognostic Value

The Hata classification has important prognostic implications for predicting the need for vascular interventions, though it does not predict major adverse cardiovascular events (MACE). 4

Key prognostic findings include:

  • Type V disease (extensive involvement) independently predicts higher likelihood of requiring vascular intervention
  • Type I disease shows protective association against needing intervention (OR 0.10,95% CI 0.01-0.53)
  • Greater anatomical disease extension correlates with increased procedural risk
  • Type V exhibits the greatest clinical severity, while Types IIb and III show the lowest severity 2

Diagnostic Imaging Approach

The initial evaluation should include thoracic aorta and branch vessel CT or MRI to investigate aneurysm or occlusive disease (Level of Evidence: C) 3. The 2021 ACR/Vasculitis Foundation guidelines conditionally recommend noninvasive imaging over catheter-based angiography as a disease activity assessment tool 5.

Common Pitfalls

  • Do not assume classification type predicts MACE risk: While Type V predicts intervention needs, MACE is better predicted by diagnostic delay and male sex rather than anatomical distribution 4
  • Recognize that clinical remission does not equal disease quiescence: 92.4% of patients may achieve clinical remission while disease progression continues on imaging, emphasizing the need for ongoing vascular surveillance 4
  • Geographic ancestry matters: Consider Japanese versus Indian patterns when interpreting imaging, as this affects expected distribution 3, 1

Treatment Implications

The classification guides monitoring intensity rather than initial treatment choice. All active Takayasu arteritis requires high-dose corticosteroids (prednisone 40-60 mg daily) plus non-glucocorticoid immunosuppressive agents regardless of type 3, 5. However, elective revascularization must be delayed until inflammation is quiescent (Level of Evidence: B) 3.

Patients with Type V disease and baseline aortic insufficiency require particularly vigilant surveillance for intervention needs 4.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.